The research, published recently in the prestigious journal Nature Communications, addresses the intricate mechanisms by which microglia, the brain’s resident immune cells, modulate neurogenesis in the adult hippocampus. This brain region is critically involved in learning and memory formation, and the authors’ findings spotlight how immune surveillance and signaling by microglia can directly influence the creation and integration of new neurons into existing neural circuits.

Yu (Agnes) Luo, PhD, the study’s corresponding author and a professor and vice chair for research at the Department of Molecular and Cellular Biosciences, emphasizes the vital importance of understanding adult neurogenesis not only for our fundamental grasp of brain function but also for its implications in neurodegenerative diseases and mood disorders. “Adult neurogenesis is fundamental for maintaining cognitive flexibility, mood regulation, and memory consolidation,” Luo explains. “Elucidating the cellular crosstalk that facilitates this process could lead to breakthroughs in therapies aimed at combating cognitive decline and neurological diseases.”

The debate over adult neurogenesis has been contentious, with early skepticism regarding whether new neurons are generated in the adult human brain at all. It was not until a seminal 2025 study published in the journal Science that definitive evidence demonstrated ongoing neurogenesis within the hippocampus in adult humans. Building on this foundational knowledge, Luo’s laboratory sought to untangle the regulatory factors that enable or inhibit this process.

Central to their discoveries is the identification of microglia as dynamic regulators of neurogenesis. These cells, historically viewed largely as immune sentinels responding to injury or disease, are now recognized for their nuanced roles in maintaining neural homeostasis. The study reveals that the activation state of microglia critically determines their impact on neural stem cells — either promoting or suppressing the generation of newborn neurons depending on microglial signaling pathways.

One of the study’s most significant innovations lies in deciphering the role of transforming growth factor-beta (TGF-beta) signaling within microglia. Activated microglia devoid of TGF-beta signaling were found to foster neurogenesis via a sophisticated molecular conversation with neural stem cells. This bidirectional communication, described technically as microglia-neural stem cell signaling crosstalk, orchestrates the balance between immune function and neural regeneration, suggesting potential targets for rejuvenating the aging brain.

Though the current investigations were conducted in animal models to manipulate and observe cellular interactions within controlled environments, efforts are underway to translate these insights into human biology. Luo is collaborating with Ziyuan Guo, PhD, from the Department of Pediatrics at the College of Medicine, whose expertise lies in engineering human central nervous system organoids that integrate microglia, serving as sophisticated platforms for studying human neurodevelopment and neurodegeneration in vitro.

The project further benefited from cutting-edge single-cell RNA sequencing techniques, executed in partnership with Krishna Roskin, PhD, at Cincinnati Children’s Hospital. This technology allowed the team to map gene expression profiles at an unprecedented resolution, illuminating specific cellular signaling networks at work within the neurogenic niche. Such granular data deepens our understanding of the cellular diversity and molecular dialogues underpinning brain plasticity.

Longer-term, this research holds promise for revolutionary therapies aiming to harness adult neurogenesis for cognitive rejuvenation, particularly in the context of aging and Alzheimer’s disease. Joshua Peter, a lead author and former graduate student of the Luo lab, articulates this vision: “By understanding and potentially enhancing neurogenesis, we hope to mitigate cognitive decline and promote healthier brain aging, opening new therapeutic windows for Alzheimer’s and related disorders.”

The technology prowess gained through this research has also equipped emerging scientists like Peter and Kierra Ware, another Luo lab alumnus, with valuable expertise in translational neurobiology and biomedical research, ensuring a pipeline of innovators committed to pushing the frontiers of neuroscience.

Collaboration across institutions and disciplines bolsters the robustness of these findings. Contributors include Shane Liddelow from NYU Grossman School of Medicine, experts from the UChicago Medicine and NorthShore University HealthSystem partnership, as well as researchers from the German Center for Neurodegenerative Diseases. This international and interdisciplinary teamwork underscores the global effort to unveil the mysteries of the adult brain’s regenerative potential.

Taken together, these discoveries affirm the profound plasticity of the adult brain and redefine the roles of immune cells beyond mere defense—positioning them as key architects in neural regeneration. As research advances, the modulation of microglia signaling pathways stands as a promising frontier, potentially leading to innovative treatments that will transform the management of cognitive impairment and neurodegeneration.

Subject of Research: Animals
Article Title: Immune cells regulate adult hippocampal neurogenesis via TGF-beta signaling pathways
News Publication Date: 9-Feb-2026
Web References: https://link.mediaoutreach.meltwater.com/ls/click?upn=u001.Y87PxWj8gU0RPezaehlkQRumQp8DAV-2BIv5WY6NyDcQqHN8Z-2BdpeZskdMyt8HlyJw0QkquyffdCOBWlJdDryvEg-3D-3DXBNn_3u918C8n0AVqyOWIFY55-2FDiESquxCTmQYlctRdeNLb0NLrGGlSyBNqKdXsxFShdPePkdbvrsJ0pQpH1-2FRvZ2L95YGU6QKpJgQfrPVXO647nQC99gwtVEOZ-2FGItgrDTgSauOD-2FrgqIijCJX6XZlugVfwPREO8eBEE01y7TCf-2Fh7S3Z3bQC2KsBt8lFSGTB6z3HB789O9BMXX3-2BGCmi-2FTuesenNNNUtHrZ-2B6WuYJxxa7-2FugONrzt4VpjS2cJn-2BA5WzLhiXSe6vnfjzZ0mFcPxaDfoVQ0GhyDc9BkLOSdIWgBJuSfNcIUhr9Im6E7Lg-2BDGhAuTLltP3MWigsDpSXpo939xbBR2ldOvxxJsb10xFoLBMcRuHNFjLZCq9warBI1UfcaaanviprEqgl1pMAcsi1Q-3D-3D
References: Nature Communications, 9-Feb-2026
Keywords: Adult neurogenesis, Hippocampal neurogenesis, Immune system, Microglia, TGF-beta signaling, Neural stem cells, Brain plasticity, Alzheimer’s disease, Cognition, Neurodegenerative diseases, Neurons, Brain development

At the heart of this research is Dr. Jed Hartings, a prominent figure in the Department of Neurosurgery at UC. Hartings explains that during spreading depolarizations, brain cells lose their electrical charge, rendering them incapable of functioning properly. This electrical disruption acts similarly to a dead battery, and the consequences can be catastrophic as it spreads like waves in a pond, interfering with every aspect of cellular function. This domino effect can persist for days or even weeks, severely compromising patient outcomes.

Traditional SD detection has relied heavily on neural electrode strips, which are invasive and require specialized training for clinicians to interpret the data collected. Given the complexities and nuances involved, few physicians possess the specialized skill set necessary to diagnose SDs effectively and reliably. This limitation not only creates a bottleneck in patient care but also increases the risk of overlooking critical brain activity.

Recognizing these challenges, Hartings and his research team embarked on an ambitious project to develop a machine learning model capable of automating this intricate process. By leveraging over 2,000 hours of monitored brain data from 24 patients hospitalized for severe TBI, the researchers identified more than 3,500 unique SD events. This substantial dataset ensured that the machine learning model was trained thoroughly, allowing it to discern patterns in brain activity that typically precede or coincide with SDs.

The performance of the model in identifying SDs has yielded remarkable results. It demonstrated a high degree of sensitivity and specificity, matching the capabilities of expert human scorers. Even more significantly, the algorithm was able to detect instances of SD that were missed by human reviewers, potentially due to a greater degree of objectivity inherent in machine learning processes. The researchers tested the algorithm’s limits and found it could still perform effectively with minimal data—just one voltage reading every ten seconds—far less than the conventional method, which typically captures 256 data points per second.

Hartings emphasizes the broader implications of these findings, particularly the potential for automated SD detection technology to revolutionize care in neurosurgical centers. Currently, many centers are eager to monitor SDs but lack the necessary expertise and resources. By automating the detection process, healthcare systems can reduce barriers to effective patient monitoring and potentially expedite the delivery of care. This shift could significantly enhance patient outcomes and spur further research into effective treatments for SDs.

However, the journey is far from over. Hartings cautions that while the preliminary results are promising, additional validation and development are crucial before fully replacing human expertise with automation. Recognizing the value of human oversight, he highlights that even enhanced machine learning tools can only complement existing clinical practices. The immediate benefit would be a reduction in workload for medical professionals, along with improved response times, as automated alerts can notify physicians to review patient data sooner and take necessary actions.

Despite the optimistic trajectory of this research, certain limitations remain. One significant hurdle is the requirement for invasive electrode strips, which restricts patient monitoring predominantly to those undergoing surgery. To extend the benefits of SD monitoring to a broader patient population, Hartings and his colleagues are actively exploring non-invasive detection methods. The ongoing development of such technologies could enable expanded access to rapid and effective SD monitoring for a wide array of patients suffering from acute brain injuries.

The research team is not resting on its laurels. Their current objectives include refining the machine learning algorithm with larger data sets and testing the software’s practicality for clinical applications. The aim is to partner with additional institutions to trial the software in real-world settings. This collaborative approach will help in the continuous evolution of the tool and its integration into patient care.

Moreover, they are conducting clinical trials like the INDICT trial, aimed at identifying optimal treatment modalities for patients experiencing SDs. The urgency of this research is underscored by the realization that having a more precise detection method coupled with enhanced treatment options could substantially improve patient care and recovery outcomes.

In conclusion, the work being done by Dr. Hartings and his team at the University of Cincinnati is pioneering a new frontier in the monitoring and treatment of brain injuries. Their innovative approach utilizing machine learning offers hope for automating the detection of spreading depolarizations, which could ultimately expedite the path to better patient outcomes and contribute to a better understanding of brain injuries. This research exemplifies the vital intersection between neuroscience and technology, paving the way for future advancements in clinical practice.

Subject of Research: Machine learning in detection of spreading depolarizations
Article Title: Automated detection of spreading depolarizations in electrocorticography
News Publication Date: 12-Mar-2025
Web References: Nature Scientific Reports
References: 10.1038/s41598-025-91623-7
Image Credits: Photo/Julie Forbes/University of Cincinnati
Keywords: Neurosurgery, Machine learning, Brain injuries, Clinical research, Neuroscience, Spreading depolarizations, Automated detection.